NATR NASDAQ
Nature's Sunshine Products, Inc.
1W: -3.6%
1M: -12.1%
3M: -42.5%
YTD: -40.6%
1Y: -20.0%
3Y: -24.5%
5Y: -14.0%
$12.45
-0.14 (-1.11%)
Weekly Expected Move ±2.3%
$12
$12
$12
$13
$13
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
6 relationships6
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2021-08-17
Earliest Filing
2025-07-07
Latest Filing
partner: 6
Counterparties (Filed by NATR)
6 relationshipsCompanies named in NATR's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | — | partner | Former joint venture partner whose interest in the joint ventures is being repurchased by the Company. | 2025-07-07 | View |
| Fosun Industrial Co., Ltd. | — | partner | Wholly owned subsidiary of Fosun Pharma and seller of its joint venture interests to the Company. | 2025-07-07 | View |
| D.A. Davidson & Co. | — | partner | Representative of underwriters for secondary public offering | 2025-06-27 | View |
| Fosun Pharma USA, Inc. | — | partner | Selling stockholder in secondary public offering | 2025-06-27 | View |
| Fosun Industrial Co., Limited | — | partner | Entered into an Operating Agreement and Amendment regarding the ownership and management of NSP HK. | 2021-08-17 | View |
| Nature's Sunshine Hong Kong Limited | — | partner | Jointly entered into an Operating Agreement and Amendment with the Company and Fosun Industrial Co., Limited regarding N | 2021-08-17 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-06 | Earnings Release; Officer/Director Change; Exhibits | View | |
| 2026-05-07 | Earnings Release; Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-03-10 | Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-15 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-07-31 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-07 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-06-27 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-06-02 | Departure/Election of Directors; Appointment of Officers; Other Events; Financial Statements and Exh | View | |
| 2025-05-06 | Financial Statements and Exhibits | View | |
| 2025-03-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-11 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-02-05 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-11-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-08-09 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-05-08 | Results of Operations and Financial Condition; Submission of Matters to a Vote of Security Holders; | View | |
| 2024-03-12 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-03-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2023-11-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2023-08-10 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR